Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study

<table>Frequency distribution of the participants on the CGI-III scale. This figure demonstrates the percentage of people on varying degrees of efficacy of the intervention. This takes into consideration the side effects and the benefits observed.</table>

Stem Cells International

fig2

Figure 2

Figure 2: Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study 